Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Bellicum Pharmaceuticals Shares Outstanding 2013-2020 | BLCM

Bellicum Pharmaceuticals shares outstanding from 2013 to 2020. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  
Bellicum Pharmaceuticals Annual Shares Outstanding
(Millions of Shares)
2019 5
2018 4
2017 3
2016 3
2015 3
2014 0
2013 0
2012 0
Bellicum Pharmaceuticals Quarterly Shares Outstanding
(Millions of Shares)
2020-03-31 5
2019-12-31 5
2019-09-30 5
2019-06-30 5
2019-03-31 4
2018-12-31 4
2018-09-30 4
2018-06-30 4
2018-03-31 3
2017-12-31 3
2017-09-30 3
2017-06-30 3
2017-03-31 3
2016-12-31 3
2016-09-30 3
2016-06-30 3
2016-03-31 3
2015-12-31 3
2015-09-30 3
2015-06-30 3
2015-03-31 3
2014-12-31 0
2014-09-30 0
2014-06-30 0
2014-03-31 0
2013-12-31
2012-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.039B $0.007B
Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It is focused on discovering and developing cellular immunotherapies for various forms of cancer, including both hematological and solid tumors, as well as orphan inherited blood disorders. The Company's lead clinical product candidate is BPX-501, an adjunct T-cell therapy in multiple Phase I/II clinical trials. It is also developing BPX-201, a dendritic cell cancer vaccine, which is in a Phase I clinical trial for the treatment of metastatic castrate-resistant prostate cancer. Bellicum Pharmaceuticals, Inc. is based in Houston, Texas.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $61.795B 35.07
Takeda Pharmaceutical (TAK) Japan $59.682B 10.46
Astellas Pharma (ALPMY) Japan $30.032B 0.00
Eisai (ESALY) Japan $20.944B 0.00
UCB SA (UCBJF) Belgium $17.183B 0.00
Merck (MKGAF) Germany $14.504B 0.00
Grifols, S.A (GRFS) Spain $14.170B 17.61
Catalent (CTLT) United States $12.163B 47.02
Neurocrine Biosciences (NBIX) United States $11.590B 53.56
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $9.945B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.633B 0.00
Ionis Pharmaceuticals (IONS) United States $7.589B 40.35
Orion OYJ (ORINY) Finland $6.879B 30.82
IPSEN SA ADR (IPSEY) France $6.412B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.064B 9.71
United Therapeutics (UTHR) United States $5.175B 9.81
STADA ARZNEIMI (STDAF) Germany $4.916B 0.00
Nektar Therapeutics (NKTR) United States $4.101B 0.00
Evotec AG (EVTCY) Germany $3.888B 0.00
ChemoCentryx (CCXI) United States $3.728B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.632B 396.56
FibroGen (FGEN) United States $3.281B 0.00
PTC Therapeutics (PTCT) United States $3.182B 0.00
Hypermarcas (HYPMY) Brazil $3.153B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.643B 10.86
Sage Therapeutics (SAGE) United States $2.022B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.908B 14.60
Pacira BioSciences (PCRX) United States $1.900B 38.88
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.824B 0.00
Corcept Therapeutics (CORT) United States $1.805B 17.90
Xencor (XNCR) United States $1.796B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.727B 0.00
USANA Health Sciences (USNA) United States $1.706B 17.49
Zogenix (ZGNX) United States $1.659B 0.00
Heron Therapeutics (HRTX) United States $1.653B 0.00
Akebia Therapeutics (AKBA) United States $1.584B 0.00
Karyopharm Therapeutics (KPTI) United States $1.510B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.404B 15.13
Portola Pharmaceuticals (PTLA) United States $1.399B 0.00
Indivior (INVVY) United States $1.399B 17.36
Translate Bio (TBIO) United States $1.286B 0.00
Tilray (TLRY) Canada $1.279B 0.00
Esperion Therapeutics (ESPR) United States $1.202B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.151B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.106B 49.38
ImmunoGen (IMGN) United States $0.896B 0.00
Endo (ENDP) Ireland $0.887B 1.37
BioCryst Pharmaceuticals (BCRX) United States $0.841B 0.00
Collegium Pharmaceutical (COLL) United States $0.773B 0.00
Molecular Templates (MTEM) United States $0.736B 0.00
Aerie Pharmaceuticals (AERI) United States $0.731B 0.00
Ardelyx (ARDX) United States $0.699B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.603B 0.00
Radius Health (RDUS) United States $0.590B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.584B 0.00
Harpoon Therapeutics (HARP) United States $0.570B 0.00
Innate Pharma SA (IPHYF) France $0.555B 0.00
Trillium Therapeutics (TRIL) Canada $0.528B 0.00
Siga Technologies (SIGA) United States $0.486B 0.00
DURECT (DRRX) United States $0.484B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.457B 11.05
Calithera Biosciences (CALA) United States $0.442B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.425B 16.60
Ocular Therapeutix (OCUL) United States $0.385B 0.00
Flexion Therapeutics (FLXN) United States $0.377B 0.00
MEI Pharma (MEIP) United States $0.372B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.360B 0.00
Organogenesis Holdings (ORGO) United States $0.354B 0.00
TherapeuticsMD (TXMD) United States $0.340B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.324B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.307B 0.00
Concert Pharmaceuticals (CNCE) United States $0.300B 0.00
Lannett Co Inc (LCI) United States $0.298B 6.54
Oasmia Pharmaceutical AB (OASMY) Sweden $0.293B 0.00
CASI Pharmaceuticals (CASI) United States $0.271B 0.00
Redhill Biopharma (RDHL) Israel $0.260B 0.00
Rafael Holdings (RFL) United States $0.241B 0.00
Xeris Pharmaceuticals (XERS) United States $0.218B 0.00
VAXART, INC (VXRT) United States $0.216B 0.00
IMV INC (IMV) Canada $0.211B 0.00
OptiNose (OPTN) United States $0.211B 0.00
KalVista Pharmaceuticals (KALV) United States $0.202B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.197B 0.00
Taiwan Liposome (TLC) Taiwan $0.194B 0.00
Aquestive Therapeutics (AQST) United States $0.193B 0.00
Jounce Therapeutics (JNCE) United States $0.192B 4.59
PROFOUND MEDICL (PROF) Canada $0.191B 0.00
Nature's Sunshine Products (NATR) United States $0.174B 22.85
Summit Therapeutics (SMMT) United Kingdom $0.133B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.128B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.123B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.123B 0.00
Recro Pharma (REPH) United States $0.112B 0.00
Champions Oncology (CSBR) United States $0.110B 0.00
PharmAthene (ALT) United States $0.108B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.095B 0.00
CV Sciences (CVSI) United States $0.094B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.092B 0.00
Sundial Growers (SNDL) Canada $0.091B 0.00
SCYNEXIS (SCYX) United States $0.078B 0.00
CTI BioPharma (CTIC) United States $0.077B 0.00
Otonomy (OTIC) United States $0.076B 0.00
Heat Biologics (HTBX) United States $0.071B 0.00
Onconova Therapeutics (ONTX) United States $0.070B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.067B 0.00
Biomerica (BMRA) United States $0.066B 0.00
Nivalis Therapeutics (ALPN) United States $0.063B 0.00
RENEURON GP (RNUGF) United Kingdom $0.060B 0.00
Infinity Pharmaceuticals (INFI) United States $0.056B 0.00
MediWound (MDWD) Israel $0.055B 0.00
Iterum Therapeutics (ITRM) Ireland $0.054B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.054B 32.18
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.052B 0.00
Aclaris Therapeutics (ACRS) United States $0.052B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.048B 102.54
Lipocine (LPCN) United States $0.047B 0.00
GTx (ONCT) United States $0.047B 0.00
Natural Alternatives (NAII) United States $0.044B 0.00
Addex Therapeutics (ADXN) Switzerland $0.040B 0.00
Forward Pharma (FWP) Denmark $0.040B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.039B 0.00
Neos Therapeutics (NEOS) United States $0.036B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.035B 0.00
PolarityTE (PTE) United States $0.034B 0.00
ElectroCore (ECOR) United States $0.034B 0.00
Mannatechorporated (MTEX) United States $0.033B 6.33
Dipexium Pharmaceuticals (PLXP) United States $0.030B 0.00
Cardiome Pharma (CORV) Canada $0.028B 0.00
Jaguar Animal Health (JAGX) United States $0.026B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.025B 0.00
Bio-Path Holdings (BPTH) United States $0.020B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.019B 0.00
ProPhase Labs (PRPH) United States $0.019B 0.00
Novan (NOVN) United States $0.018B 0.00
Flex Pharma (SLRX) United States $0.016B 0.00
Regulus Therapeutics (RGLS) United States $0.014B 0.00
Cyanotech (CYAN) United States $0.012B 0.00
Shineco (TYHT) China $0.012B 0.00
China SXT Pharmaceuticals (SXTC) China $0.012B 0.00
Vical (BBI) United States $0.011B 0.00
RXi Pharmaceuticals (PHIO) United States $0.011B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.007B 0.00
HANCOCK JAFFE (HJLI) United States $0.007B 0.00
Midatech Pharma (MTP) United Kingdom $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00